Table 1.
LH and hCG content (immunoreactivity) of different urinary hMG preparations
Product | LH IU/vial (SD) | hCG IU/vial (SD) | LH/hCG ratio | Study |
---|---|---|---|---|
Pergonal | 13.49 (3.6) | 3.39 (1.7) | 3.98 | Wolfenson et al. [4] |
Humegon | 5.77 (1.0) | 6.86 (1.8) | 0.84 | Wolfenson et al. [4] |
Menopur | 0.29 (5.2) | 9.61 (2.3) | 0.03 | Wolfenson et al. [4] |
Menopur | 0.48 (1.7) | 9.05 (3.3) | 0.05 | Wolfenson et al. [4] |
Menopur | 0.39 (3.1) | 11.06 (1.8) | 0.04 | Wolfenson et al. [4] |
Menopur | 0.85 (0.18) | 11.3 (1.0) | 0.08 | Giudice et al. [6] |
Menopur | 3 (range 2.7–5.3) | 10 (range 9.9–11.2) | 0.03 | Van de Weijer et al. [5] |
hCG human chorionic gonadotropin; IU international units; LH luteinising hormone; hMG human menopausal gonadotropin.